Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P51787: Variant p.Tyr315Ser

Potassium voltage-gated channel subfamily KQT member 1
Gene: KCNQ1
Feedback?
Variant information Variant position: help 315 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Tyrosine (Y) to Serine (S) at position 315 (Y315S, p.Tyr315Ser). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and aromatic (Y) to small size and polar (S) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In LQT1. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 315 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 676 The length of the canonical sequence.
Location on the sequence: help EFGSYADALWWGVVTVTTIG Y GDKVPQTWVGKTIASCFSVF The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         EFGSYADALWWGVVTVTTIGYGDKVPQTWVGKTIASCFSVF

Mouse                         EFGSYADALWWGVVTVTTIGYGDKVPQTWVGKTIASCFSVF

Rat                           EFGSYADALWWGVVTVTTIGYGDKVPQTWVGKTIASCFSVF

Pig                           EFGSYADALWWGVVTVTTIGYGDKVPQTWVGKTIASCFSVF

Rabbit                        EFGSYADALWWGVVTVTTIGYGDKVPQTWVGKTIASCFSVF

Xenopus laevis                QFGSYADALWWGVVTVTTIGYGDKVPQTWIGKTIASCFSVF
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 676 Potassium voltage-gated channel subfamily KQT member 1
Intramembrane 300 – 320 Pore-forming; Name=Segment H5
Mutagenesis 324 – 324 V -> L. Has a voltage-gated potassium channel activity. Inhibition of voltage-gated potassium channel activity by KCNE4.
Mutagenesis 326 – 326 K -> R. Has a voltage-gated potassium channel activity. Disrupts KCNE4-mediated voltage-gated potassium channel activity inhibition.
Mutagenesis 327 – 327 T -> V. Has a voltage-gated potassium channel activity. Disrupts KCNE4-mediated voltage-gated potassium channel activity inhibition.
Mutagenesis 328 – 328 I -> L. Has a voltage-gated potassium channel activity. Inhibition of voltage-gated potassium channel activity by KCNE4.



Literature citations
KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome.
Donger C.; Denjoy I.; Berthet M.; Neyroud N.; Cruaud C.; Bennaceur M.; Chivoret G.; Schwartz K.; Coumel P.; Guicheney P.;
Circulation 96:2778-2781(1997)
Cited for: VARIANTS LQT1 ARG-168; CYS-174; GLN-190; MET-254; LYS-261; ASP-269; ARG-309; SER-314; SER-315; ALA-320; ARG-325; VAL-341; PHE-342; VAL-344; THR-371 AND CYS-555; Novel KCNQ1 and HERG missense mutations in Dutch long-QT families.
Jongbloed R.J.E.; Wilde A.A.M.; Geelen J.L.M.C.; Doevendans P.; Schaap C.; van Langen I.; van Tintelen J.P.; Cobben J.M.; Beaufort-Krol G.C.M.; Geraedts J.P.M.; Smeets H.J.M.;
Hum. Mutat. 13:301-310(1999)
Cited for: VARIANTS LQT1 SER-184; ARG-189; SER-314; SER-315; ARG-345; PRO-373 AND ARG-392;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.